// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis.

Jess Mateos Martn - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Role of CO2 monitoring in the diagnosis and management of paediatric sleep disordered breathing

Federica Trucco - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Sleep apnoea

N/A

The NIVO Study: attitudes to ventilation following acute NIV.

Nicholas Lane - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nivolumab

Prevalence and correlates of cigarillo use in European Union member states

Filippos T. Filippidis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?

Helen Morris - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pirfenidone

Association between exhaled volatile organic compounds and urinary levels of oral corticosteroids within the U-BIOPRED Cohort

Paul Brinkman - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Prednisolone

Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?

Shoaib Faruqi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Characterisation of TRPA1 activation on sensory nerves

Xue Chen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydrogen peroxide

Persistent blood eosinophilia and COPD exacerbation risk after ICS withdrawal from triple therapy in the SUNSET study

John R. Hurst - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

salmeterol + fluticasone

COPD pulmonary rehabilitation - good enough for ILD patients?

Kate Martin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Late Breaking Abstract - Overlap of SGRQ and CAT-defined chronic mucus hypersecretion in the SPIROMICS cohort: implications for digital health

Marni Stott-Miller - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Interventions to improve symptom control and quality of life in patients with interstitial lung disease: a systematic review and meta-analysis

Sabrina Bajwah - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

What can we learn from Idiopathic Pulmonary Fibrosis Registries?

Taha Lodhi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo

Daniela Riccardi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Fluticasone propionate

The anti-tussive effects of an inhaled LABA are maintained after chronic treatment

Michael Wortley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Formoterol

The effect of double-stranded RNA on extracellular matrix deposition in an in vitro model of the airway mucosa

Chiara Banas - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Ascorbic acid

Evaluating the accuracy of commercially available finger pulse oximeters in a hospital setting

Rory Mcdermott - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Automated Python Algorithm Analysis of Benign Pulmonary Nodules Discharged after 2 years Surveillance

Richard Lee - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of early life factors with wheezing phenotypes in preterm-born children compared to term-born children

Sarah Kotecha - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Dietary nitrate supplementation enhances the benefit of pulmonary rehabilitation in people with COPD

Matthew Pavitt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved